He has started prescribing a new kind of screening — the Shield blood test — for his patients who are hesitant to get a colonoscopy. For a decade, we've had stool collection kits like Cologuard. In ...
Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease who are eligible to receive the drug.
Finding signs of cancer early significantly increases the chance of survival by allowing for treatment when the cancer is ...
FDA grants orphan drug designation to HLX22 for gastric cancer, with a phase 2 trial showing improved progression-free ...
Antibody-drug conjugates and their development remains a central theme in ongoing research within the realm of ovarian cancer ...
Cancer survivors, especially those treated for head and neck cancers, often face speech and swallowing difficulties. Speech-language therapy plays a major role in helping them regain communication ...
Deborah Wong, MD, PhD, discusses the toripalimab combination that is now considered standard of care in nasopharyngeal cancer ...
The Fulton County Gun Club is hosting its 10th annual Clays for Cancer event then at 3916 N. Meridian Road, Rochester.
Dean Berhaupt has become the first patient to receive CAR T-cell therapy in Albany, marking a significant milestone for ...
The EU approved AstraZeneca's Enhertu for certain breast cancer patients and Imfinzi for resectable NSCLC, showing ...
Cancer survivors can reduce their ongoing risk of death by sticking to diet and exercise guidelines recommended by the ...
The FDA has approved Gozellix (kit for the preparation of gallium Ga 68 gozetotide injection), a radioactive diagnostic agent for prostate cancer detection.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback